T0	Outcomes 91 126	lower respiratory tract infections.
T1	Outcomes 652 673	clinical improvement.
T2	Outcomes 858 895	satisfactory bacteriological response
T3	Outcomes 1101 1173	mild adverse effects (nausea, vomiting, headache, hypotension and rash).
T4	Outcomes 1207 1216	tolerated
T5	Outcomes 1242 1248	deaths
T6	Outcomes 1360 1378	effective and safe